期刊文献+

四环素类药物治疗骨关节炎新进展

下载PDF
导出
摘要 骨性关节炎(Osteoarthritis,OA)是一种发病率随年龄明显增加的退行性关节病变,其最基本的病理变化是由于力学和生物学因素引发关节软骨组织合成与降解之间的正常关系失衡。临床上主要表现为膝关节疼痛、变形和活动受限。近年来,针对OA治疗的药物研究在不断进展,其中,四环素类抗生素(tetracyclines,TCs)的非抗生素作用在OA治疗中的意义,逐渐得到人们重视,为骨关节炎的治疗提供了新的思路。下面就近几年TCs治疗骨关节炎的研究作一概述。
出处 《农垦医学》 2009年第1期57-59,共3页 Journal of Nongken Medicine
  • 相关文献

参考文献16

  • 1Pelletier J P, Mattel - Pclletier J. DMOAD developments: present and future[ J ]. Bull NYU Hosp Jt Dis,2007,65 (3) :242 - 248
  • 2Lee H M , Golub L M, Cao J, et al. CMT - 3, a non - antimicrobial tetracycline( Tcs ), inhibits MT1 - MMP activity: relevance to cancer[ J]. Gurr Med chem, 2001, 8:257 - 260
  • 3Israel HA , Ramamurthy Ns, Greenwald R et al. The potential role of doxycycline in the treatment of osteoarthritis of the temporomandibular joint [ J ]. Adv Dent Res, 1998,12 ( 2 ) :51 - 55
  • 4Lohmander KS, Brandt K D, Mazzuca S A. Use of the plasma stromelysin (matrixmetallop roteinase 3 ) concentration to predict joint space narrowing in knee osteoarthritis[ J]. Arthritis Rheum, 2005, 52 (10) : 3160-3167
  • 5刘俊.一氧化氮对骨关节病软骨退变影响的研究进展[J].中国中医骨伤科杂志,2003,11(5):62-64. 被引量:2
  • 6Pelletier J. p, J. Martel Pelletier. The Novartis - ILAR heumatologyprize 2001 osteoarthritis : from molecule to man [ J ]. Arthritises, 2002,4(1) :13 -19
  • 7Topsakal C, Kilic N, Ozveren F, et al. Effects of prostaglandin El, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxanase ( PON1 ) activities, and homocysteine levels in an animalmodel of spinal cord injury [ J ]. Spine, 2003, 28 : 1643 - 1652
  • 8Borderie D, Hemvann A, Hilliquin P, et al. Tetracyclines inhibit nitrosothiol production by eytokine - stimulated osteoarthritic synovial cells[J],Inflamm Res,2001,50(8) :409-414
  • 9刘世清,何炳书,彭昊,周华,张思胜.四环素对骨关节炎模型关节液及血液中iNOS和NO水平的影响[J].武汉大学学报(医学版),2004,25(3):299-301. 被引量:4
  • 10孙永生,娄思权.骨性关节炎发病分子机制研究进展[J].中国骨与关节损伤杂志,2005,20(8):571-573. 被引量:54

二级参考文献47

  • 1王卫国,娄思权,佘华,夏家辉.TGF-β_2转染关节软骨细胞的实验研究[J].中华骨科杂志,2003,23(7):434-438. 被引量:31
  • 2吴海山,钱齐荣,顾其胜.关节内注射透明质酸钠预防兔骨关节炎的实验研究[J].中华骨科杂志,1996,16(1):37-39. 被引量:93
  • 3娄思权.骨关节炎的病理与发病因素[J].中华骨科杂志,1996,16(1):56-59. 被引量:229
  • 4创伤性关节患者血清和关节液中自由基水平及意义[J].Joural of Practial Orthopedics,2001,7(3).
  • 5Bohme GA, Bon C, Stutzmam JM, et al. Possible involvement of nitric oxide long--term portentiation. Eur J Pharmacol. 1991,199: 379-381.
  • 6Blanco FJ, Ochs RL, Schwatz H et al. Am Jpatol, 1995,146,75-78.
  • 7Nathan C, and Xie QW. Regulation of biosyhthesis of nitric oxide. J. Biol Chem. 1994,263:13725-13728.
  • 8Evans CH, Stefanovic-- Racic M,and Lancaster J. Nitric oxide and its role in orthopaedic dieases. Clin Olin Ortho and Related Res. 1995,312:275-294.
  • 9Dawson TM, Steiner SP, Dawson VL, et al.Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity in primary cortical cultures. Pro Natl Acad Sci. USA 1991,88: 6368 - 6371.
  • 10Morris JR SM, Billiaar TM. New insight into the regulation of inducible nitric oxide synthase. AM J Physol.1994,266:829-839.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部